Galaxy Medicare last traded at ₹17.45 (2026-10-13). Over the past month the stock moved +5.4%, three months the stock moved -11.6%, year the stock moved -22.3%. Its closing range over 52 weeks is ₹15.25 – ₹23.00, with the latest close 24.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.[1]
Business Profile[1] Galaxy manufactures, trades, and exports medical devices with a focus on POP bandages, medical tapes, surgical dressings, and wound care products. It operates through its own brands, OEM supply, government/institutional sales, exports, and trading channels.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 21.27 | 1.37 | 6.44 | 1.40 | 0.92 |
| Sep 2025 | 18.73 | 2.86 | 15.27 | 2.02 | 1.33 |
| Mar 2025 | 21.96 | 2.15 | 9.79 | 1.66 | 1.40 |
| Sep 2024 | 17.24 | 2.50 | 14.50 | 1.71 | 1.44 |
In the latest year (Mar 2026), Galaxy Medicare reported sales of ₹40.00 crore (+2.0%) and net profit of ₹3.42 crore (+1.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 40.00 | 4.23 | 10.58 | 3.42 | 2.25 |
| Mar 2025 | 39.20 | 4.65 | 11.86 | 3.37 | 2.84 |
| Mar 2024 | 35.84 | 4.97 | 13.87 | 3.71 | 3.13 |
| Mar 2023 | 30.94 | 2.35 | 7.60 | 1.57 | 5.16 |
| Mar 2021 | 28.57 | 2.16 | 7.56 | 0.72 | 2.57 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +8.3% | +15.8% | +9.4% | +2.0% |
| Operating profit growth | +8.8% | +111.5% | -6.4% | -9.0% |
| Net profit growth | +118.1% | +136.3% | -9.2% | +1.5% |
| EPS growth | +100.8% | -39.3% | -9.3% | -20.8% |
| OPM % | 7.6% | 13.9% | 11.9% | 10.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Galaxy Medicare.
Get Free AI Stock Analysis FREE →No recent news available for Galaxy Medicare.
Galaxy Medicare shares were last quoted at ₹17.45 (+4.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Galaxy Medicare has a price-to-earnings (P/E) ratio of 7.87 and a price-to-book (P/B) ratio of 0.67. The industry P/E is 44.09.
The 52-week high of Galaxy Medicare is ₹34.15 and the 52-week low is ₹15.15.
The market capitalisation of Galaxy Medicare is about ₹26.85 crore.
This page is for information and is not investment advice. As per the data shown here, Galaxy Medicare has a 3-year ROE of 14.00%, 3-year profit growth of 58.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 72.98% of Galaxy Medicare.
Galaxy Medicare belongs to the Medical Equipment/Supplies/Accessories sector.
All Medical Equipment/Supplies/Accessories stocks · Browse all stocks A–Z